Carisoprodol (Soma)

Subscribe to Selected New Research on Carisoprodol

598 relevant articles (6 outcomes, 49 trials/studies) found for this Drug

Description: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)

Also Known As:

Soma; Belmac Brand of Carisoprodol; Carisoma; Carter Horner Brand of Carisoprodol; Forest Brand of Carisoprodol; GM Pharmaceuticals Brand of Carisoprodol; Mio Relax; Schein Brand of Carisoprodol; Somalgit; Soprodol; Vanadom; Wallace Brand 1 of Carisoprodol; Wallace Brand 2 of Carisoprodol; Wallace Brand 3 of Carisoprodol; Carisoprodate; Isobamate; Isomeprobamate; Isopropylmeprobamate; Carbamic acid, (1-methylethyl)-, 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester

Relationship Network

Drug Context: Research Results

Organic Chemicals: 40

Experts

1.	Reeves, Roy R: 4 articles (07/2008 - 02/2003)
2.	Routledge, Jacqueline A: 3 articles (11/2003 - 06/2003)
3.	Davidson, Susan E: 3 articles (11/2003 - 06/2003)
4.	Burns, Meriel P: 3 articles (11/2003 - 06/2003)
5.	Høiseth, Gudrun: 2 articles (04/2008 - 09/2007)
6.	Sørlid, Hanne Kristin: 2 articles (04/2008 - 01/2005)
7.	Mørland, Jørg: 2 articles (09/2007 - 01/2005)
8.	Bramness, Jørgen G: 2 articles (09/2007 - 01/2005)
9.	Swindell, Ric: 2 articles (11/2003 - 09/2003)
10.	West, Catharine M L: 2 articles (11/2003 - 06/2003)

Related Diseases

1.	Ganglion Cysts (Ganglion) 08/01/1989 - "However, mean ganglion cell soma diameter was significantly greater than normal in both the area centralis and temporal retina after neonatal enucleation" 03/01/1990 - "Exposure to KA eliminated mainly small neurons of soma area 5-15 microns2, and medium-sized ganglion cells of soma area 15-25 microns2" 03/01/2006 - "This study describes the different types of inward currents (Ii) recorded from the soma of isolated cochleovestibular ganglion (CVG) cells of the embryonic chicken, Gallus gallus" 01/01/2006 - "CONCLUSION: A comparison of the data collected from the two cohorts of mice used for this study suggests that the initial site of damage in this disease is to the axons in the optic nerve, followed by the subsequent death of the ganglion cell soma." 08/01/2005 - "Studies of cultured adult pelvic ganglion neurons also demonstrated that NTN stimulated soma growth" Order ALL the reference details at left...
2.	Body Weight (Weight, Body) 01/01/2001 - "In the present study, we examined the length of the 2nd ceratobranchial cartilages (which unfold the dewlap), muscle fiber size, nerve cross-sectional area, and motoneuron soma size, as well as measures of body size (snout-vent length and body weight) at post-hatching days 1, 30, 60, 75, and 90" 04/15/1994 - "Here we show that in juveniles the soma size of these neurons increases as a linear function of body weight" 05/01/1990 - "From three-dimensional diameter measurements of eleven kinds of cells pertaining to five different organs, which were excised from eleven adult mammals (nine species) whose body weight range was 40 g to 450 kg, we calculated the corresponding cell soma areas (A), volumes (V), and finally their area-volume ratios (A/V)" 08/01/2000 - "In the carisoprodol in 0.5% methylcellulose study, males in the 200 mg/kg group and females in the 100 and 800 mg/kg groups had significantly greater mean body weights and body weight gains than did the vehicle controls" 08/01/2000 - "The final mean body weight gain of males administered 1,600 mg/kg carisoprodol in corn oil was significantly less than that of the vehicle controls; the final mean body weights and body weight gains of female rats in the 800 and 1,600 mg/kg groups were significantly greater" Order ALL the reference details at left...
3.	Spasm (Spasms) 06/01/2008 - "CASE SUMMARY: A 28-year-old woman with severe back muscle spasm took carisoprodol 2800 mg/day before and throughout an uncomplicated pregnancy and while exclusively breast-feeding her infant during the first month after birth" 04/01/1993 - "Carisoprodol use should be limited to short-term treatment of acute musculoskeletal conditions involving significant muscle spasm" 08/01/1965 - "USE OF CARISOPRODOL IN SYMPTOMATIC THERAPY OF PAINFUL MUSCLE SPASM." 09/01/1961 - "Carisoprodol for muscular spasm and pain seen in industrial and general practice." 02/01/2008 - "Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm." Order ALL the reference details at left...
4.	Fibromyalgia (Fibrositis) 09/20/1993 - "Fibromyalgia--a relationship between psyche and soma?]" 06/01/1989 - "Thus, the combination of carisoprodol and paracetamol (acetaminophen) and caffeine are effective in the treatment of fibromyalgia." 06/01/1989 - "Forty-three of fifty-eight (74.1%) female patients with fibromyalgia completed an eight-week treatment period testing the combination of carisoprodol, paracetamol (acetaminophen) and caffeine versus placebo" 06/01/1989 - "Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo." Order ALL the reference details at left...
5.	Back Pain (Backache) 02/01/2008 - "RESULTS: Carisoprodol was significantly more effective than placebo for patient-rated global impression of change (2.24 vs. 1.70; p < 0.0001) and patient-rated relief from starting backache (1.83 vs. 1.12; p < 0.0001)" 02/01/2008 - "CONCLUSIONS: In this study, patients with acute muscle spasm of the lower back had significantly greater and more rapid relief from starting backache, and had improved functional status, as measured by the RMDQ, during treatment with carisoprodol 250-mg tablets compared to placebo" 09/01/2004 - "Cochrane Library, MEDLINE, and EMBASE databases were searched (time frame: 1960 through January 2004; search terms: back pain, carisoprodol, cyclobenzaprine, metaxalone, muscle relaxants, and pharmacotherapy) and reference lists of identified articles were hand-searched" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Acetaminophen (Paracetamol)
2.	Tablets
3.	Methylcellulose (BFL)
4.	Corn Oil (Oil, Corn)
5.	Caffeine (No Doz)
6.	Melatonin
7.	Carisoprodol (Soma)
8.	Testosterone (Sustanon)
9.	Retinaldehyde (Retinal)
10.	Ibotenic Acid

Related Therapies and Procedures

1.	Fluid Therapy (Oral Rehydration Therapy)
2.	Conformal Radiotherapy
3.	Axotomy
4.	Transplants (Transplant)
5.	Microspheres (Microsphere)

Best Treatments:
Research Summary Report
on Ganglion Cysts

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 97 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>